These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 138208)

  • 1. Immunological monitoring of long-surviving renal transplant recipients.
    Thomas J; Thomas F; Mendez-Picon G; Lee H
    Surgery; 1977 Feb; 81(2):125-31. PubMed ID: 138208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved renal allograft survival using the mixed lymphocyte culture for selection of nonidentical living related donors.
    Riggio RR; Saal SD; Katz EB; Tapia L; White R; Chami J; Sheigh JS; Sullivan JF; Stenzel KH; Stubenbord WT; Whitsell JC; Rubin AL
    Trans Am Soc Artif Intern Organs; 1975; 21():90-5. PubMed ID: 1096421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of renal transplant recipients using immunologic monitoring.
    Miller J; Kyriakides G; Flaa C
    Transplant Proc; 1979 Mar; 11(1):360-3. PubMed ID: 156425
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of lymphocyte-dependent antibody in kidney transplantation.
    Jeannet M; Vassalli P
    Transplantation; 1976 Nov; 22(5):493-9. PubMed ID: 793105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.
    Pfeffer PF; Sødal G; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():72-8. PubMed ID: 6216585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evidence of a specific defect in effector cell formation following kidney and liver allotransplants in humans].
    Wonigkeit K; Pichlmayr R
    Chir Forum Exp Klin Forsch; 1977 Apr; ():269-73. PubMed ID: 156112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological monitoring as a guide to the management of transplant recipients.
    Thomas FT; Lee HM; Lower RR; Thomas JM
    Surg Clin North Am; 1979 Apr; 59(2):253-81. PubMed ID: 155890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
    Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    Transplant Proc; 1978 Jun; 10(2):479-81. PubMed ID: 150082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity and chronic renal allograft rejection.
    Thomas JM; Thomas FT; Kaplan AM; Lee HM
    Transplantation; 1976 Aug; 22(2):94-100. PubMed ID: 135384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of rejection.
    Stiller CR; Sinclair NR
    Transplant Proc; 1979 Mar; 11(1):343-9. PubMed ID: 377654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-donor immune responses in prediction of transplant rejection.
    Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA
    N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological monitoring after renal transplantation from living donors].
    Laurentaci G; Favoino B; Selvaggi FP
    Minerva Chir; 1980 May; 35(10):751-60. PubMed ID: 7005731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating antibodies in allograft recipients.
    Revillard JP; Betuel H
    Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.